What is Acute Disseminated Encephalomyelitis (ADEM)?
Acute Disseminated Encephalomyelitis (ADEM) is an inflammatory disease of the central nervous system that attacks myelin – the insulating sheath that encapsulates nerve cells. Myelin allows for the efficient transmission of electrical impulses along nerve cells. When the myelin is damaged – a process called demyelination – this transmission is affected and the conduction of nerve signals can be disrupted or lost.
The onset of Acute Disseminated Encephalomyelitis (ADEM) is generally rapid and intense, and typically begins with encephalitis-like symptoms that can be either mild (i.e. fever, fatigue, headache) or severe (seizures, coma). The affected individual also experiences neurological symptoms, including weakness (sometimes to the point of paralysis), confusion, drowsiness, vision problems, and tingling or numbness.
Our recent ADEM case results
- November 11, 2014; Docket No. 10-711V. 22-year-old female received the HPV vaccine, and was subsequently diagnosed with ADEM.
- Awarded a lump sum of $50,000.
- February 18, 2014; Docket No. 09-474V. 16-year-old male received the Tdap and meningococcal vaccines. Approximately two weeks later, he was diagnosed with ADEM and continues to have headaches and urogenic bladder.
- Awarded a lump sum of $453,634.67, plus an annuity for future medical needs.
- January 18, 2013; Docket No. 10-808V. 49-year-old female who received the flu vaccine. One week later, she experienced symptoms diagnosed as ADEM.
- Awarded a lump sum of $110,000.